BA-BCS2021 POSTERS LIST
PS1: Tuesday, 18 10:30-13:00h / PS2: Wednesday, 19 10:30-13:00h / PS3: Thursday, 20 10:30-13:00h / PS4: Friday, 21 10:30-13:00h
PS (Poster Session) Poster # Presenting Author Name Presenting Author Surname Poster Title
1 PS1-1 Gabriela Pataccini CDK4/6 inhibitors and antiprogestins: therapeutic combination in PRA breast cancer experimental models
1 PS1-2 Natalia Amigo Parameters associated with metastatic dissemination are differentially modulated by specific isotypes of the retinoic acid receptor (RARs) in triple negative mammary cancer models.
1 PS1-3 Julieta Rocio Cebrón Effect of 2’-nitroflavone on the expression of receptors associated with EGFR activity in breast cancer cells
1 PS1-4 Analía Amante ANALYSIS OF AKT MOLECULAR, SUBCELLULAR AND TUMORAL CODE AS AN EXPLANATORY AND PREDICTIVE TOOL FOR THE EFFECTIVENESS OF THERAPIES AGAINST BREAST CANCER
1 PS1-5 Nicolás Luis Calzetta A potential strategy to prevent drug resistance: Chromosome instability can be prevented with no changes in the induction of cell death after Chk1 depletion
1 PS1-6 Rosalía Inés Cordo Russo Exploring the role of hyaluronan and CD44 in resistance to ErbB-2-targeted therapies in breast cancer
1 PS1-7 Lucía Fernández Chávez GEF-H1 drives tumor formation, motility, invasion and metastasis in breast cancer
1 PS1-8 Sabrina Mansilla DNA polymerase iota prevents unleashed DNA elongation to promote cell survival and genomic stability
1 PS1-9 Paula Aguirre Generation of a CRISPR/Cas9 EO771-tumor platform to study breast cancer cell – immune system interactions
1 PS1-10 Fabiana A Rossi E3 UBIQUITIN LIGASE HERC1 REGULATES BREAST CANCER CELLS MIGRATION AND INVASION
1 PS1-11 Inés Beckerman Tristetraprolin (TTP) down-regulation in mammary epithelial cells induces developmental delay and DUSP-6 phosphatase overexpression
1 PS1-12 Emilia Bogni LIVER X RECEPTOR (LXR) activation may affect breast cancer risk through induction of tristetraprolin (TTP) in mamary epithelial cells
1 PS1-13 Mariana Andrea Bojorge Morphological and histological studies in mammary glands of GH-overexpressing transgenic mice.
1 PS1-14 Fátima Liliana Monteiro Inhibition of SETD7 methyl-transferase activity impairs mammary epithelial cell differentiation and lactogenesis
1 PS1-15 María Belén Bordignon Phenotypic and functional characterization of memory Natural Killer (NKm) cells in patients with Breast Cancer (BC)
1 PS1-16 Romina Canzoneri Study of Foxp3 expression in tumor microenvironment and peripheral blood of breast cancer patients
1 PS1-17 Liliana Scarpinelli Scarpinelli Perforator flaps in the reconstruction of Breast and thorax burnts
2 PS2-18 Sabrina Vallone Aberrant Ret expression impacts on normal mammary gland post-lactation transition enhancing cancer potential.
2 PS2-19 Micaela Nadia Stedile Tristetraprolin (TTP) Expression is Required for Mammary Progenitor Cell Survival
2 PS2-20 Noelia Victoria Miret Epigenetic changes induced by pesticide exposure reactivate LINE-1 retrotransposon in breast cancer and mammary epithelial cells
2 PS2-21 Lizeth Aixa Ariza Bareño Norcantharidine treatment inhibits in vitro parameters associated with tumor progression in triple negative breast cancer cell lines
2 PS2-22 Fátima Eneida del Valle Ferragut Dual galectin-8 and ALCAM silencing delays triple negative breast cancer progression
2 PS2-23 Agustina Ibarra Combination therapy of paclitaxel with calcitriol analogues: a new therapeutic option for Triple Negative Breast Cancer
2 PS2-24 Ayelén Ivana Pesce Viglietti Association between higher KI67 and higher proportion of effector T CD8 lymphocytes in HER2+ Breast Cancer patients
2 PS2-25 Ayelén Ivana Pesce Viglietti Peripheral blood NK bright cells are augmented in breast cancer patients non-reaching pathologic complete response to antibody anti HER2+-based therapy
2 PS2-26 Sebastián Real Establishment of two Breast Cancer Patient Derived Xenograft (PDX) lines and their respective treatment-resistant PDX variant
2 PS2-27 María Florencia Chervo RNA-seq Identifies Nuclear ErbB-2-Induced Transcriptome as a Key Driver for Triple Negative Breast Cancer Growth
2 PS2-28 Sebastián Real Working together for the family: HER oncogenes co-amplification in breast cancer
2 PS2-29 Daniela Nasif Molecular cross-talk between ER and ID4 in breastcancer
2 PS2-30 YIOVANA VERÓNICA OKRAINE Methods to monitor the relevance of M phase in the synthetic lethal potency of Polo-like Kinase 1 inhibitors
2 PS2-31 Georgina Daniela Scalise Epigenetic modifications associated to breast cancer in metabolic syndrome-like disease mice models
2 PS2-32 Sofia Masuelli Epigenetics, Bioelectricity and Laterality of Breast Cancer
2 PS2-33 Adiba Khan Investigating the role of CBFB in breast cancer
2 PS2-34 Carla Maria Felcher Analysis of RUNX-CBFβ as a relevant regulator of RSPO3 expression in breast cancer cells
2 PS2-35 Maria Sol Rodriguez RUNX2 OVEREXPRESSION GENERATES ENDOCRINE RESISTANCE IN HUMAN LUMINAL BREAST CANCER XENOGRAFTS
3 PS3-36 Johanna Abigail DÍAZ ALBUJA Role of Thyroid Hormones in Breast Cancer resistance to chemotherapy.
3 PS3-37 Agustina Florencia Carnevale ACE2 downregulation as a resistance mechanism to VEGFR-tyrosine kinase inhibitor (VEGFR-TKI) treatment in breast cancer therapy.
3 PS3-38 Julieta Martino CYTOKINESIS INHIBITION INDUCES SYNTHETIC LETHALITY AND MITOTIC ABNORMALITIES IN BRCA2-DEFICIENT CELL LINES
3 PS3-39 Noelia Victoria Miret Emerging role of AhR / c-Src signaling in breast cancer cell migration induced by tumor acidosis
3 PS3-40 Sofia Bruni Soluble tumor necrosis factor alpha fosters tumor growth, innate immune evasion and resistance to lapatinib in HER2-positive breast cancer
3 PS3-41 Andrés Bechis Effect of Lapatinib and All-Trans Retinoic Acid (ATRA) combined treatment on mammary cancer stem cells derived from HER2 negative cell lines
3 PS3-42 Juan Manuel Fernandez Muñoz Influence of Structural Variants of the TRIC-CCT complex´s genes on patient survival and the main molecular pathways related to breast cancer.
3 PS3-43 Isabel Luthy In silico identification of ADRA2A-associated miRNA expression  as biomarkers for disease-free survival in breast cancer subtypes
3 PS3-44 Martín Emilio García Solá Integrative single-cell transcriptomic analysis unveils alternative polyadenylation modulation in the mouse mammary gland.
3 PS3-45 Mariana Gantov Differentiation of 3T3-L1 preadipocytes into beige adipocytes regulate mammary tumor cells behavior
3 PS3-46 Priscila Ayelén Pagnotta SOLUBLE FACTORS FROM THE TUMOR-ADIPOCYTE INTERPLAY STIMULATE MORPHOLOGICAL AND METABOLIC CHANGES IN 3T3-L1 ADIPOCYTES
3 PS3-47 maria francisca pavicic rojas THE KININ B1 RECEPTOR INDUCES THE EXPRESSION AND SECRETION OF IL-10 AND M-CSF FROM BREAST CANCER CELLS, FAVORING THE DIFFERENTIATION AND MIGRATION OF MACROPHAGES
3 PS3-48 IRAIDI RODRIGUEZ Low-grade inflammation is related to KLK3 levels in breast cancer
3 PS3-49 Paula Lucía Farré Identification of circulating miRNAs associated to Kaiso and triple negative breast cancer in mice model
3 PS3-50 Maria Cecilia Perrone Potential use of PI3K pathway effectors and associated microRNAs as biomarkers of breast cancer prognosis
3 PS3-51 MAURO ALDO MONTANARO GLYCEROL-3P-ACYLTRANSFERASE 2 EXPRESSION IN MDA CELLS MODULATES THE EXPRESSION OF LONG NON-CODING RNAS LINKED TO SURVIVAL PREDICTION IN BREAST CANCER PATIENTS
3 PS3-52 Andrea Werbach Establishing histopathological criteria for breast cancer research
4 PS4-53 Noelia Victoria Miret Exposure to endocrine disruptors induces proangiogenic factors in MDA-MB-231 human breast cancer cells
4 PS4-54 Marianela Lasagna Chlorpyrifos subthreshold exposure induces epithelial-mesenchymal transition in breast cancer cells
4 PS4-55 Lorena Vanesa Zárate Environmental exposure and mammary tumors: the pesticides action on LM3 murine breast cancer cells
4 PS4-56 Marianela Sciacca Implications of TGF-β in the early progression of breast cancer
4 PS4-57 Lucía Andrea Vottero Gustin Effect of Roscovitine and mifepristone on luminal breast cancer cell proliferation
4 PS4-58 Maria Celeste Rodriguez-Baili Isolation and Characterization of Extracellular Vesicles coming from Breast Cancer Cells and Macrophages
4 PS4-59 Inês Gomes Direito Protein aggregation and hormone-related cancers: a novel approach to predict and overcome endocrine therapy resistance?
4 PS4-60 Eliana Noelia Alonso EVALUATION OF MYCOTHERAPEUTIC ANTITUMORAL POTENTIAL OF THE PLEUROTUS OSTREATUS I-FRACTION IN BREAST CANCER.
4 PS4-61 Kerri Sweeney Investigating the tumour suppressor function of RUNX1 in breast cancer.
4 PS4-62 Sofía María Sosa RUNX1 PARTICIPATION ON TNBC
4 PS4-63 Natalia B Fernandez REGULATION OF RUNX1 BY ANDROGEN RECEPTOR, A NEW POTENCIAL MECHANISM OF TNBC PROGRESSION
4 PS4-64 Agustina Roldán Deamicis AR and ErbB-2 Interaction in Triple Negative Breast Cancer
4 PS4-65 Virginia Figueroa Targeting androgen receptor and WNT pathway in endocrine-resistant mammary carcinomas with high AR and low ER and PR levels
4 PS4-66 María Cecilia Sanmartin Low Oct4 expression in mesenchymal stem cells contributes to the development of the bone marrow pre-metastatic niche in advanced breast cancer patients
4 PS4-67 Sebastian Omar Siri CIN-independent cell death in S phase induced by pol eta depletion
4 PS4-68 Sofía Venerus Arbilla Unveiling the mechanism of regulation of excessive fork elongation by Polymerase Iota
4 PS4-69 Mayra Lis Sottile EFFECT OF OLAPARIB IN COMBINATION WITH DOXORUBICIN ON MDA-MB-231 BREAST CANCER CELL LINE
4 PS4-70 Matias Gatto Expression of a fusion peptide that mimics the epitope of the HER2 antigen and its application for trastuzumab detection